Free Trial

Predictive Oncology (POAI) Insider Trading & Ownership

Predictive Oncology logo
$0.85 +0.02 (+2.12%)
As of 07/3/2025 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Predictive Oncology (NASDAQ:POAI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.44%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$13.66K
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$30.40K
Get POAI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Predictive Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

POAI Insider Buying and Selling by Quarter

Predictive Oncology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/25/2023Charles Lee Sr Nuzum SrDirectorSell10,000$3.04$30,400.00  
12/15/2022Daniel E HandleyDirectorBuy300$8.20$2,460.00  
12/2/2022Raymond F VennareDirectorBuy250$10.40$2,600.00  
12/2/2022Robert L MyersCFOBuy439$11.40$5,004.60  
11/29/2022Daniel E HandleyDirectorBuy500$7.20$3,600.00  
(Data available from 1/1/2013 forward)

POAI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Predictive Oncology includes Charles Lee Sr Nuzum Sr, Daniel E Handley, Raymond F Vennare, and Robert L Myers. Learn more on insiders at POAI.

3.44% of Predictive Oncology stock is owned by insiders. Learn more on POAI's insider holdings.

The following insider sold POAI shares in the last 24 months: Charles Lee Sr Nuzum Sr ($30,400.00).

Insiders have sold a total of 10,000 Predictive Oncology shares in the last 24 months for a total of $30,400.00 sold.



This page (NASDAQ:POAI) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners